Axion BioSystems, Inc. — Form D

Axion BioSystems, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-05. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
GLENN J EPSTEINDirectorUPPERVILLE, VA
DAVID J GIBSONDirectorSLINGERLANDS, NY
MICHELLE J JARRARDDirectorATLANTA, GA
Thomas J O'BrienDirectorTulsa, OK
JAMES J ROSSDirectorDECATUR, GA
JAY J TEICHDirectorBERLIN, MA
Thomas J O'BrienExecutive OfficerTulsa, OK
JAMES J ROSSExecutive OfficerDECATUR, GA
James RossDirectorMetairie, LA
James RossExecutive OfficerMetairie, LA
Mark AllenDirectorGrand Island, NE
Greg DaneDirectorTucker, GA
Stephen J DeWeerthExecutive OfficerDecatur, GA
Swaminathan J RajaramanExecutive OfficerAtlanta, GA
Glenn A EpsteinDirectorNorth Chatham, NY
Mark J AllenDirectorAtlanta, GA
Julian A BraggExecutive OfficerDecatur, GA
Edgar J BrownExecutive OfficerDecatur, GA
Stephen DeWeerthExecutive OfficerDecatur, GA
Edgar BrownExecutive OfficerDecatur, GA
Swaminathan RajaramanExecutive OfficerAtlanta, GA

Other filings by this issuer (4)

FiledFormOfferingSold
2016-05-17D$6.3M$6.3M
2012-05-09D$3.5M$3.2M
2010-07-28D$2.5M$2.1M
2009-04-30D$1.0M$1.0M

More